Category Patents/Designs/Trade Secrets

What To Watch Out For In The EU-Mercosur FTA Negotiations: Consequences For Access To Medicines

As negotiations take place this week, an evaluation of the impact of one of the TRIPS-plus measures of the Mercosur/EU FTA on the prices of medicines in Brazil has been released. Based on the draft of the agreement, by their calculations, an additional USD 444 million would be necessary to be spent by the public health system for the purchase of six medicines alone, write Marcela Fogaça Vieira and Gabriela Costa Chaves.

WHO Advisory Group Report On Fair Pricing Forum Released

The report from a meeting of a World Health Organization informal advisory group on challenges of medicines pricing and organising a Fair Pricing Forum this spring has been made public. The report shows the analysis and assertions of the diverse group, as well as questions and plans to take forward.

UN Development Programme Calls For Reform Of IP And Investor Protection Regimes

A United Nations Development Programme report released today places importance on transforming global institutions, and establishing fair trade and investment rules. The report calls for global reform of the intellectual property rights regime and investor protection regime. In addition, the report ranks countries on their human development level, putting Norway first followed by Australia and Switzerland.

A Look At Optimal Patent Regimes For Canada

A new policy brief from the Centre for International Governance Innovation, in Waterloo, Canada argues that Canada should pursue a weaker national patent regime. Acknowledging that Canada already has agreed to certain levels of protection through international treaties and trade agreements, Blit warns that future agreements that strengthen intellectual property protections would not benefit Canada.

Do US Patent Incentives Need To Change To Get The ‘Cancer Moonshot’ Off The Ground?

In December, the United States Congress passed a bill with a monumental goal: engaging the private sector to work with each other, and with the government, to develop new treatments for cancer. The mechanics of cancer research, however, may require fundamental changes to our patent system if the initiative is to be successful. Intellectual Property Watch recently sat down with Jacob Sherkow, associate professor of law and affiliated faculty at the Innovation Center for Law and Technology at New York University Law School, to discuss challenges to overcome to get the Moonshot off the ground.